Sydney Catalyst is a multi-disciplinary, multi-institutional endeavour established with core funding from the Cancer Institute NSW and based at the University of Sydney.
Read more
The consortium brings together teams of clinicians and researchers from ~30 member organisations across NSW with the purpose of facilitating the rapid translation of scientific discoveries into clinical policy and practice to improve patient outcomes.
Sydney Catalyst aims to improve health outcomes for people affected by cancer through a comprehensive translational research program.
Presentation Seminars
Join us as our panel of speakers discuss the hot topic: "Can Disruptive Ideas Transform Cancer Research?" REGISTRATION NOW OPEN Confirmed participants Associate Professor Natalka Suchowerska ...
News Articles
The biennial Sydney Catalyst International Translational Cancer Research Symposium was held at the Garvan Institute of Medical Research last month. We had a fantastic turnout with very positive f...
Newsletters
Thank you once again to all our members who attended the International Translational Cancer Reserach Symposium at the Garvan last month. Congratulations to the award recipients! Read ab...
Want to be featured in a Sydney Catalyst Case Study? Contact us at SydneyCatalyst@ctc.usyd.edu.au for more information | | Cannabinoids &nb...
Sydney Catalyst is proud to announce the recipients of Pilot & Seed funding for 2019. This year we awarded a record $357,500 in funding to seven recipients across the translational spectru...
In 2018, Sydney Catalyst launched a new podcast series, "Cataysis", discussing important issues in the cancer space, from the controversial to the common sense. With eight episodes n...